First Patient Enrolled in GORE® TAG® Thoracic Branch Endoprosthesis Early Feasibility Study
First Early Feasibility Study of a Gore Device Will Assess Treatment of Aortic Arch Aneurysms
GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan
Device designed to bring endovascular therapy options to patients previously considered untreatable
GORE® DrySeal Flex Introducer Sheath Advances Care through Access
New sheath provides exceptional access to challenging anatomies and branch vessels
Improved GORE® DrySeal Sheath with Hydrophilic Coating Launches in Europe
New Product Engineered to Increase Sheath Lubricity, Minimize Coating Particulation for Easier Insertion and Removal in Treating Patients with AAA and TAA
Gore Launches Lower Profile GORE® EXCLUDER® AAA Endoprosthesis Contralateral Leg
Components in US and Europe
Gore Achieves 40 Million Implants Sold Worldwide as it Celebrates 40 Years of Performance
Milestones a testament on its 40-year legacy of designing devices to improve patient outcomes
GORE® EXCLUDER® Iliac Branch Endoprosthesis is First Dedicated System of Its Kind Registered in Australia and New Zealand
First Successful Implants Providing Endovascular Repair to Iliac Arteries Completed in Australia
GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains FDA Approval
Gore designed all-in-one system to preserve iliac artery blood flow in patients with iliac or aortoiliac aneurysms
GORE® TIGRIS® Vascular Stent Gains Health Canada Approval for Treatment of Peripheral Artery Disease
Novel device combines proven technology with modern adaptations to provide support in even the most challenging anatomies
W. L. Gore & Associates Receives Innovative Technology Designation from Vizient, Inc. for GORE® SYNECOR Biomaterial
Designation recognizes products that bring improvements to the healthcare industry